BULLISHWHALES
BullishWhales · Congress · Trade Detail
NYSE: ABTAbbott Laboratories
RepublicanHouse

David B. McKinley bought Abbott Laboratories (NYSE: ABT)

David B. McKinley (R-WV), a U.S. Representative, has disclosed 5 trades in Abbott Laboratories (ABT) since 2018, 3 purchases and 2 sales, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: David B. McKinley bought $1,001 - $15,000 of Abbott Laboratories (NYSE: ABT) on December 20, 2018. Since that trade, ABT is up +57.02% against the S&P 500 up +242.55%, an outperformance of -185.53%.

Across these filings, David B. McKinley has been a net buyer of ABT (a buy-to-sell ratio of 1.50). The most recent disclosed ABT transaction shown was dated September 21, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABT trades
5
Disclosed Vol
$65K
Buys
3
60%
Sells
2
40%
Buy / Sell
1.50
ratio
First → Last
2018–2022

David B. McKinley's ABT trades vs the price

ABT is up +57.02% since David B. McKinley bought on December 20, 2018, versus +242.55% for the S&P 500.

Performance since this trade

Price change since trade
+57.02%
S&P 500 change since trade
+242.55%
Outperformance vs S&P 500
-185.53%

All David B. McKinley ABT trades

TradedTypeSizeReturnEst. profit
September 21, 2022SELL$93.43+0.53%
August 28, 2020SELL$99.75-5.83%
April 30, 2020BUY$82.59+13.73%+$201
December 20, 2018BUY$59.82+57.02%+$3K
December 20, 2018BUY$59.82+57.02%+$12K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

David B. McKinley & ABT trading FAQ

Is it legal for David B. McKinley to trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did David B. McKinley buy ABT?

David B. McKinley disclosed a purchase of $1,001 - $15,000 of Abbott Laboratories (ABT) on December 20, 2018, according to public STOCK Act filings.

How has ABT performed since David B. McKinley's trade?

Since David B. McKinley bought ABT on December 20, 2018, the stock is up +57.02%, versus +242.55% for the S&P 500 over the same period, an outperformance of -185.53%.

How many times has David B. McKinley traded ABT?

David B. McKinley has disclosed 5 ABT trades since 2018 (3 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABT trades?

BullishWhales tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.

David B. McKinley's ABT tradesAll congressional filings for Abbott LaboratoriesDavid B. McKinley's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30